Glenmark life sciences IPO

Glenmark Life Sciences IPO Glenmark Life Sciences was founded in 2011 and is a leading manufacturer of active pharmaceutical ingredients (APIs). In a variety of therapeutic areas, the company develops and manufactures high-quality APIs for cardiovascular disease (CVD), neurological disease (CNS), pain management, and diabetes, gastroenteritis, antibiotics, and other pathways. In addition, it offers Contract … Continue reading Glenmark life sciences IPO